# Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model

> **NCT06969768** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 275 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06969768
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2021-02-21
- **Final completion:** 2024-02-28
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06969768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06969768, "Proteogenomics for Follicular Cell-derived Thyroid Cancer: Development of a Classification and Prognosis Prediction Model". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06969768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*